Inside the Rapid Evolution of Autoimmune Cell Therapy
The number of cell therapy assets targeting autoimmune diseases has grown more than 14-fold over the past decade, fuelled by clinical proof of concept in B-cell–driven diseases and a strategic reallocation of capital from crowded oncology markets into autoimmunity. As a result, competition is intensifying – and the ability to see the full landscape clearly is becoming a strategic advantage.
This infographic provides a data-backed view of:
- How the autoimmune cell therapy pipeline is structured today, across preclinical and clinical development
- Which therapeutic classes, targets, and dual-target strategies are emerging as focal points
- Where clinical activity is concentrated in high-unmet-need indications
- How deal-making and financing patterns signal a shift toward scalable immune-engineering platforms
By distilling these insights into a single visual narrative, the Cell Therapies for Autoimmune Diseases infographic helps leaders, scientists, and commercial teams align around where the field is heading, and where opportunity is forming.
You May Also Be Interested In…
Learn More About Autoimmune
- The Most Comprehensive Way to Search the Autoimmune Drug Development Landscape: Unique search ontologies based on Autoimmune drug and trial characteristics
- Market Leading Approach to Autoimmune Preclinical & Clinical Data Curation: Manual curation of key Autoimmune research and development data points by Autoimmune research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Autoimmune company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
